Literature DB >> 15148291

Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension.

Nikola Jeck1, Siegfried Waldegger, Angelika Lampert, Christoph Boehmer, Petra Waldegger, Philipp A Lang, Bernd Wissinger, Björn Friedrich, Teut Risler, Robert Moehle, Undine E Lang, Peter Zill, Brigitta Bondy, Elke Schaeffeler, Stephen Asante-Poku, Hannsjörg Seyberth, Matthias Schwab, Florian Lang.   

Abstract

The chloride channel ClC-Kb is expressed in the basolateral cell membrane of the distal nephron and participates in renal NaCl reabsorption. Loss-of-function mutations of ClC-Kb lead to classic Bartter syndrome, a rare salt-wasting disorder. Recently, we identified the ClC-Kb(T481S) polymorphism, which confers a strong gain-of-function effect on the ClC-Kb chloride channel. The present study has been performed to explore the prevalence of the mutation and its functional significance in renal salt handling and blood pressure regulation. As evident from electrophysiological analysis with the 2-electrode voltage-clamp technique, heterologous expression of ClC-Kb(T481S) in Xenopus oocytes gave rise to a current that was 7-fold larger than the current produced by wild-type ClC-Kb. The prevalence of the mutant allele was significantly higher in an African population from Ghana (22%) than in whites (12%). As tested in 1 white population, carriers of ClC-Kb(T481S) were associated with significantly higher systolic (by approximately 6.0 mm Hg) and diastolic (by approximately 4.2 mm Hg) blood pressures and significantly higher prevalence (45% versus 25%) of hypertensive (> or =140/90 mm Hg) blood pressure levels. Individuals carrying ClC-Kb(T481S) had significantly higher plasma Na+ concentrations and significantly decreased glomerular filtration rate. In conclusion, the mutation ClC-Kb(T481S) of the renal epithelial Cl- channel ClC-Kb strongly activates ClC-Kb chloride channel function in vitro and may predispose to the development of essential hypertension in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148291     DOI: 10.1161/01.HYP.0000129824.12959.f0

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

1.  Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels.

Authors:  G Zifarelli; A Liantonio; A Gradogna; A Picollo; G Gramegna; M De Bellis; A R Murgia; E Babini; D Conte Camerino; M Pusch
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.

Authors:  Thomas J Jentsch; Tanja Maritzen; Anselm A Zdebik
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 3.  Role of kidney chloride channels in health and disease.

Authors:  I Elias Veizis; Calvin U Cotton
Journal:  Pediatr Nephrol       Date:  2006-11-16       Impact factor: 3.714

4.  Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorption.

Authors:  Saba Sile; Digna R Velez; Niloufar B Gillani; Charles A Alexander; Charles R Alexander; Alfred L George; Scott M Williams
Journal:  Hum Hered       Date:  2007-07-25       Impact factor: 0.444

Review 5.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

6.  Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan.

Authors:  Paola Imbrici; Domenico Tricarico; Giuseppe Felice Mangiatordi; Orazio Nicolotti; Marcello Diego Lograno; Diana Conte; Antonella Liantonio
Journal:  Br J Pharmacol       Date:  2017-04-26       Impact factor: 8.739

Review 7.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

Review 8.  Novel diuretic targets.

Authors:  Jerod S Denton; Alan C Pao; Merritt Maduke
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

9.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.

Authors:  Antonella Liantonio; Alessandra Picollo; Giuseppe Carbonara; Giuseppe Fracchiolla; Paolo Tortorella; Fulvio Loiodice; Antonio Laghezza; Elena Babini; Giovanni Zifarelli; Michael Pusch; Diana Conte Camerino
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

10.  PPARgamma Agonists: Blood Pressure and Edema.

Authors:  Bonnie L Blazer-Yost
Journal:  PPAR Res       Date:  2009-12-22       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.